Rare diseases and autoimmune disordersprimary
2 projects
Core participant in both ImmunAID (autoinflammatory disorders, inflammasome, microbiome) and EJP RD (European rare disease data infrastructure and FAIR data sharing).
Organization
HACETTEPE UNIVERSITESI
Turkish research university strong in rare diseases, pandemic response, and clinical trials, expanding into AI-driven medical imaging and digital health.
University research grouphealthTR
H2020 projects
8
As coordinator
1
Total EC funding
€1.5M
Unique partners
281
What they do
Their core work
Hacettepe University is one of Turkey's leading research universities, with strong medical and life sciences faculties based in Ankara. In H2020, they contributed clinical expertise and patient data to European health research — particularly in rare diseases, autoimmune disorders, and pandemic response including COVID-19 vaccine trials. They also bring capabilities in AI-driven medical imaging (prostate cancer diagnostics) and environmental/circular economy research, reflecting a broad but health-anchored research base.
Core expertise
What they specialise in
2 projects
Contributed to EU-RESPONSE (pandemic preparedness platform trials) and VACCELERATE (European COVID-19 vaccine trial accelerator with site mapping and capacity building).
AI-driven medical imagingsecondary
1 project
Participant in ProCAncer-I, building an AI platform for prostate cancer diagnosis using cloud-based image repositories and machine learning.
Multisensory neurosciencesecondary
1 project
Coordinated MultiSense, studying dynamics of multisensory integration using system identification approaches in zebrafish and weakly electric fish.
Circular economy and construction waste recoveryemerging
1 project
Participated in ICEBERG, their largest-funded project (EUR 535K), focused on BIM-based pre-demolition audits and advanced sorting for circular building materials.
Science education and citizen engagementemerging
1 project
Contributed to MOST, connecting schools to communities through open schooling and environmental citizenship programs.
Evolution & trajectory
How they've shifted over time
Early focus
Rare diseases and biomedical data
Recent focus
Pandemic response and digital health
Their early H2020 work (2018–2019) was firmly rooted in biomedical research — rare diseases, autoimmune inflammation, multiomics data integration, and FAIR data principles. From 2020 onward, the portfolio diversified significantly: they entered pandemic response (EU-RESPONSE, VACCELERATE), AI-powered medical imaging (ProCAncer-I), circular economy (ICEBERG), and even science education (MOST). This broadening suggests a university actively expanding its European research footprint beyond its traditional medical strengths into digital health, environmental engineering, and societal engagement.
Hacettepe is moving from pure biomedical research toward applied digital health (AI imaging, clinical trial platforms) and interdisciplinary topics — expect future projects at the intersection of clinical data and AI.
Collaboration profile
How they like to work
Role: active_partnerReach: European37 countries collaborated
Hacettepe operates almost exclusively as a consortium participant (7 of 8 projects), joining large European networks rather than leading them. Their single coordination was a focused MSCA fellowship (MultiSense), suggesting they lead niche scientific work but join broad consortia for large-scale health and environment initiatives. With 281 unique partners across 37 countries, they are well-connected and comfortable working in diverse, multinational teams — a reliable partner who integrates into existing structures rather than demanding the lead.
Impressively broad network for 8 projects: 281 unique consortium partners spanning 37 countries, reflecting participation in very large health consortia like EJP RD and VACCELERATE. Their reach extends well beyond Turkey's immediate region into pan-European and global collaborations.
Why partner with them
What sets them apart
Hacettepe is Turkey's most active health-focused university in H2020, offering consortium builders access to a large patient population, clinical trial sites, and medical faculty expertise — assets that are often underrepresented in EU projects. Their combination of clinical medicine, emerging AI capabilities, and willingness to work across disciplines (from rare diseases to circular economy) makes them a versatile partner. For coordinators building health or digital health consortia, Hacettepe provides geographic diversity (Widening country) plus genuine research depth.
Notable projects
Highlights from their portfolio
- ICEBERGTheir largest single EU contribution (EUR 535K) and a surprising diversification into circular economy — far from their medical core, signaling institutional ambition.
- VACCELERATEPart of the EU's flagship COVID-19 vaccine trial accelerator, demonstrating Hacettepe's clinical trial capacity and pandemic-readiness at European scale.
- MultiSenseTheir only coordinated project — a focused MSCA fellowship in computational neuroscience, revealing niche expertise in sensory systems and system identification.
Cross-sector capabilities
Digital health and AI-driven diagnosticsCircular economy and construction waste managementScience education and public engagementNeuroscience and sensory systems research
More in Health & Biomedical
See all Health & Biomedical organizations →KOBENHAVNS UNIVERSITET
Denmark's largest research university, excelling in genomics, CRISPR, microbiome science, ancient DNA, and climate research across 696 H2020 projects.
Open →
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France's national biomedical research agency — 400+ H2020 projects spanning neuroscience, infectious disease, cancer, and omics-driven diagnostics.
Open →
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany's leading research university in molecular biosciences and translational medicine, with 303 H2020 projects and exceptional ERC grant concentration.
Open →